News Detail
Amsterdam, 11 Feb 2025: The European Medicines Agency (EMA) and the European Commission have developed a standard procedure for certain high-risk medical device manufacturers to ask for scientific advice from a panel of experts regarding their clinical development strategies and ......
View Details
Source : Regulatory Focus
European Medicines Agency
EMA
European Commission
standard procedure
high-risk medical device manufacturers
clinical development strategies
clinical investigationsscientific advice from a panel of experts
Related News
- Enforce regulations, strengthen penalties to fight the menace of counterfeit drugs: Parliamentary Panel (25-03-2025)
- Supplement firm Bioventra warns of online fakes (25-03-2025)
- FDA drug approvals drops, but smaller pharma leads innovation: GlobalData (25-03-2025)
- No staff involved in promoting fake drugs, vaccination: Odisha Health Minister (25-03-2025)
- Centre to introduce standardised hospital billing format to ensure transparency (24-03-2025)
- CDSCO asks MSME pharma firms to apply online for Schedule M extension (24-03-2025)
- Father and son arrested for unlicensed medicine sales, concealed drugs in cowshed (24-03-2025)
- AI-driven device by PGI set to transform neuropathic pain diagnosis (24-03-2025)
- Chhattisgarh EOW Arrests Five Officers in ₹660 Cr Procurement Scam (24-03-2025)
- Man caught at Silchar Medical College for allegedly overpricing medicines (24-03-2025)